A phase II trial to investigate the efficacy of TF-0023

Trial Profile

A phase II trial to investigate the efficacy of TF-0023

Planning
Phase of Trial: Phase II

Latest Information Update: 10 Jun 2016

At a glance

  • Drugs TF 0023 (Primary)
  • Indications Stroke
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jun 2016 New trial record
    • 20 Jun 2015 The company will start the this trial in 20-40 sites in the US from July, 2015, according to a Techfields Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top